Evidence map›Paper›PMID 32182684›Full record

ReviewCancers2020

Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single

Alessandro Liquori, Mariam Ibañez, Claudia Sargas, Miguel Ángel Sanz, Eva Barragán, José Cervera

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 150 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Atypical singleBlood neoplasia · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Discrepancies in the Detection ofDiseases (Basel, Switzerland) · 2026
    Article
  11. Case report:Frontiers in oncology · 2026
    Article
  12. Article
  13. A novelFrontiers in oncology · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Uncovering theGenes · 2025
    Review
  19. Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alessandro LiquoriAccredited Research Group in Hematology and Hemotherapy, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
Mariam IbañezDepartment of Hematology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Claudia SargasAccredited Research Group in Hematology and Hemotherapy, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
Miguel Ángel SanzDepartment of Hematology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Eva BarragánDepartment of Hematology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.ORCID 0000-0001-6735-0038
José CerveraDepartment of Hematology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ESInstituto de Investigación Sanitaria La Fe · ES

Funding

European Regional Development Fund CB16/12/00284Generalitat Valenciana GVA/2018/004; GV/2019/084Instituto de Salud Carlos III PI16/01113, PI16/00665, PI18/1472, PI19/00812
6 · The paper itself

Abstract

Although acute promyelocytic leukemia (APL) is one of the most characterized forms of acute myeloid leukemia (AML), the molecular mechanisms involved in the development and progression of this disease are still a matter of study. APL is defined by the

Indexed as

acute promyelocytic leukemiaAPLisoformminimal residual diseaseMRDNGSPML-RARArelapsesplicing

Identifiers

PMID32182684
PMCPMC7139833
OpenAlexW3009639630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.